glp-1 drug news Can one do it all? Reviewing the expanding clinical universe of agonists GLP-1 drugs can be ‘too

van Lanen AS, de Bree A, Greyling A

There dont seem to be any health issues related to having too much thiamine, riboflavin, pantothenic acid, biotin, or cobalamin

It is one of the amino acids (20 amino acids) that, together with the others, form the proteins, that is to say that it can be synthesized in the organism from other amino acids such as valine, isoleucine or glutamic acid, however it is considered a "conditioned essential amino acid" or semi-essential since in conditions of physical or psychological stress, trauma, infection, intense training, etc., its consumption is superior to its synthesis: the body demands so much glutamine that it is not able to synthesize it in sufficient quantity

The clinical efficacy of glutathione is also supported by large-scale patient-reported outcomes among people managing the overlapping triad of Long COVID, ME/CFS, and POTS/dysautonomia, where glutathione therapies are frequently rated among the more helpful interventions for this complex neuroimmune symptom cluster